Ductal carcinoma in situ: recent history and areas of controversy.

about

Ductal carcinoma in situ: recent history and areas of controversy.

Item

http://www.wikidata.org/entity/Q46164882

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Ductal carcinoma in situ: recent history and areas of controversy.

@en

Ductal carcinoma in situ: recent history and areas of controversy.

@nl

type

Item

label

Ductal carcinoma in situ: recent history and areas of controversy.

@en

Ductal carcinoma in situ: recent history and areas of controversy.

@nl

prefLabel

Ductal carcinoma in situ: recent history and areas of controversy.

@en

Ductal carcinoma in situ: recent history and areas of controversy.

@nl

P1476

Ductal carcinoma in situ: recent history and areas of controversy.

@en

P2093

Melvin J Silverstein

http://www.w3.org/2001/XMLSchema#string

Michael D Lagios

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis

The influence of margin width on local control of ductal carcinoma in situ of the breast.

Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast.

Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

Choosing treatment for patients with ductal carcinoma in situ: fine tuning the University of Southern California/Van Nuys Prognostic Index.

P304

21-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TBJ.12359

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

269419325

http://www.w3.org/2001/XMLSchema#string

P698

25494706

http://www.w3.org/2001/XMLSchema#string